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Abstract 
Background & Aims:  Inflammatory bowel disease is thought to be rare in Libya. The aim is to determine the prevalence 
of juvenile onset inflammatory bowel disease in Libya. Setting: Al-Fateh childrens’ hospital, Benghazi, Libya. Methods: This is 
a retrospective study of all cases diagnosed over 10 years (1997-2006) with either ulcerative colitis, Crohn’s disease or 
indeterminate colitis. Inclusion criteria were age <15 years at time of presentation who were resident in the eastern part of 
the country and who diagnosed with inflammatory bowel disease. Clinical features were outlined using a proforma. Results:  
Sixteen cases were diagnosed with inflammatory bowel disease, of whom 11 were males (M:F ratio of 1.5:1). The prevalence 
and incidence rates in the year 2006 were 3.6 and 0.9 per 100,000 children, respectively. The incidence rate increased from 
0.2 in 2002 to 0.9 in 2006 (Z score of 39.87, p= 0.00). The age at presentation ranged from 5 months to 14 years. Nine had 
Crohn’s disease (6 males) and 6 had ulcerative colitis (4 males). One patient had indeterminate colitis. The most common 
clinical features were diarrhea in 10 (62.5%), abdominal pain, anorexia and weight loss in 9 (56.2%), anemia in 7 (43.75%) 
and vomiting in 6 (37%). Ileopancolitis was found in 3 patients whereas 6 patients had ileocecal disease. Conclusions:  
Childhood inflammatory bowel disease in this population is not so rare and it is increasing. The clinical pattern is similar to 
that reported by others. 
 
IC= Indeterminate colitis 
 GIT= gastrointestinal tract. 
Abbreviations
IBD= inflammatory bowel disease 
CD= Crohn’s disease, UC= Ulcerative colitis 
Key words: Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease, Indeterminate colitis, Juvenile onset inflammatory 
bowel disease 
 
Introduction 
Inflammatory bowel disease (IBD) includes a 
heterogeneous group of immunologically mediated 
inflammatory conditions of the gastrointestinal tract (GIT) 
with or without extraintestinal manifestations. Major 
members of this group are Crohn's disease (CD) and 
ulcerative colitis (UC).  Both of these disorders are chronic 
diseases characterized by remissions and relapses. Crohn's 
disease can directly involve any part of the gastrointestinal 
tract, whereas ulcerative colitis involves only the colon.   
The clinical manifestations of Crohn's disease in particular 
are varied and include poor growth, abdominal pain, 
diarrhea, constipation, rectal bleeding, fever, and 
anaemia. Ulcerative colitis, on the other hand, is 
characterized by bloody diarrhea and abdominal pain 
among other symptoms. However, CD can present with 
colitic features similar to those of UC. Indeterminate colitis 
(IC) is another less common member of the group and its 
diagnosis rests on the exclusion of other causes of colitis.  
Some believe that it is a temporary stage towards the 
development of CD or UC [1]. However, others find it a 
clearly distinct member of the group [2]. 
 
The aetiology of IBD is still a mystery in spite of 
extensive research in the field. It is thought that 
environmental factors play an important role as evidenced 
by a relatively low concordance rate among identical 
twins. However, the higher frequency of IBD in first 
degree relatives indicates a role for genetics in its etiology 
[3]. 
 
Inflammatory bowel disease occurs with a variable 
frequency in different parts of the world. It is a common 
observation that IBD is prevalent in industrialized 
countries as it is seen in Europe and USA but much less 
common in the southern part of the globe [4-6]. Twenty 
to twenty five percent of CD and UC cases, respectively, 
present during childhood [7].  
 
Neither the prevalence of childhood-onset IBD nor its 
clinical profile has been described, and only a few reports 
have been published on IBD in Arab and Middle Eastern 
countries. These reports show that IBD is not common in 
this part of the world [8-10]. 
 
The importance of environmental factors in the 
development of IBD is further substantiated by the 
increasing frequency of IBD in areas that used to have a 
distinctly low prevalence [11]. Westernization of the life 
style in these areas is thought to be a contributing factor 
to this rise in IBD frequency in spite of lack of a hard 
causal relationship. We see in our practice that there has 
been an increase in the number of cases referred to us for 
possible IBD in the last decade. We therefore carried out a 
retrospective descriptive study on IBD in Eastern Libya to 
know the prevalence of childhood IBD and its clinical 
profile. 
 
Material and methods 
A retrospective study was performed on the children 
diagnosed as having either CD or UC or indeterminate 
colitis (IC). Benghazi is the second major city in Libya and 
its hospitals function as referral hospitals for the rest of 
the eastern part of the country.  As a rule, all children with 
suspected and /or diagnosed IBD are evaluated and 
followed up at the gastroenterology-hepatology clinic of 
Al-fateh Childrens' Hospital (AFCH), which is a major 
teaching hospital and the only pediatric referral hospital in 
the whole eastern region. However, since some 
adolescents might as an exception looked after by adult 
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physicians, we looked at the records of adult 
gastroenterology clinics in Benghazi area as well (one at 
El-Keish polyclinic and another one at Al-jamhouriya 
hospital). Inclusion criteria were as follows: presence of 
IBD, age ￿15 years at the time of presentation, 
presentation within the last 10 years (1997-2006), and 
residence in the east of Libya. More common differential 
diagnoses, such as amoebiasis, bacterial infections, 
tuberculosis and allergy, were for all practical purposes 
ruled out by conventional methods, such as stool 
examination, culture techniques, imaging, tuberculin 
testing, radioallergosorbent tests, elimination and 
challenge dietary maneuvers, and therapeutic trials, as 
needed. The usual workout of these patients included 
history taking, clinical examination (including screening for 
signs of vitamin deficiency) and anthropometric 
assessment (height, weight and mid-upper arm 
circumference). Local growth charts were used to assess 
growth [12, 13]. Puberty was graded according to the well 
known Tanner’s staging [14]. All patients were subjected 
to the following investigations: full blood count, 
erythrocyte sedimentation rate (ESR), serum calcium, 
phosphorus, alkaline phosphatase and albumin, in addition 
to blood urea and serum creatinine. C-reactive protein and 
serum ferritin were done only in the more recent cases. 
The diagnosis was based on clinical, endoscopic, 
radiological and histopathologic findings. All patients were 
endoscoped, except for one in whom the diagnosis was 
based on post-operative histopathology of an excised 
ileocaecal mass. Data on the structure of the population 
were obtained from a census carried out in 2006 by the 
National Data and Documentation Bureau.  According to 
this census, the annual growth rate over the period 1996-
2006 is 1.83%. We used this figure to estimate the 
population size over the years of our study. Prevalence 
and incidence rates were expressed as the number of 
cases per 100,000 children under 15 years old. Results 
were expressed as ranges, means ± standard deviation 
(SD) and percentages. A z-test at a confidence level of 
95% was used to test the statistical significance of any 
possible change in prevalence or incidence. EpiCalc-2000 
version 1.02 software was used for this purpose. 
 
Results 
The number of people aged < 15 years in the 
catchment area was 441,371. Sixteen patients had IBD 
giving a total prevalence and incidence rates of 3.6 and 
0.9 per 100,000 in the year 2006, respectively. Fifteen 
patients were registered at AFCH and one at Al-
jamhouriya hospital. The incidence rate increased 4-folds 
from 0.2 per 100,000/year in the year 2002 to 0.9 per 
100,000/year in 2006 with a Z score of 39.87 (p= 0.00) 
(table 1). The prevalence rate increased from 1.2 per 
100,000 in 2002 to 3.6 per 100,000 in 2006, with a Z 
score of 71.33 (p = 0.00). IBD prevalence in Benghazi 
governorate in the year 2006 was 6 per 100,000. Table 2 
shows the individual prevalence rates of CD and UC in the 
studied governorates. Eleven of our patients were males 
(M:F ratio =1.5:1). The age at presentation ranged from 5 
months to 14 years with a mean of 10.3 ± 2.8. Nine 
patients had CD (males =6) with a mean age of 8.3± 4.2 
years (range: 9 months-14 years). Six patients had UC (4 
males) with a mean age of 8±4 years (range 2.5-13 
years). One patient who was 5 months old at the time of 
presentation had indeterminate colitis. One patient was 
initially diagnosed as UC and few years later turned out to 
be CD. Time elapsed between onset of symptoms and 
diagnosis mostly ranged from 2 months to 4 years, but in 
one case this took 8 years. 
 
Diarrhea was the most common clinical feature and 
seen in 10 (62.5%) of IBD cases particularly in those with 
CD (77%). One patient with Crohn’s disease had 
constipation as a prominent chronic symptom. Anorexia, 
abdominal pain, weight loss and rectal bleeding were each 
found in 9 patients in various combinations. However, all 
patients with UC had rectal bleeding whereas just 3 out of 
9 CD patients had it (100% vs 33%). Linear growth was 
impaired in 5 patients with pubertal delay in 2 of them. 
Perianal disease including fistulas, abscesses, tags and 
nodules was seen in 4 CD patients (44% of Crohn’s). Well 
defined extraintestinal manifestations were seen in one 
patient in the form of mono-articular arthritis and the 
same patient had extensive aphthous ulceration of the 
mouth. Less well defined symptoms such as arthralgias 
and muscle pains were seen in four IBD patients. Two 
patients were subjected to operation for a right iliac fossa 
mass. Three patients with CD and one with UC were 
classified as having severe illness. 
 
Table 1 Incidence and prevalence rates of IBD over the study 
period 
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1997  368677  0  0  0  0  
1998  376754  2  0.53085    2  0.53085  
1999  384831    0    2  0.519708  
2000  392909  1  0.254512  3  0.763537  
2001  400986  1  0.249386  4  0.997542  
2002  409062  1  0.244461  5  1.222307  
2003  417139  2  0.479456  7  1.678095  
2004  425217  2  0.470348  9  2.116567  
2005  433294  3  0.692371  12  2.769483  
2006  441,371  4  0.906267  16  3.625068  
Investigations 
Hemoglobin level at presentation ranged from 7-13.5 
(10.4±1.75) gm/dl. Anaemia at presentation was found in 
seven patients (43.8%). ESR was high in 7 out of all 
patients and C-reactive protein in 2 out of 7 cases 
subjected to the test.  All UC patients had distal colitis. 
The localization of the disease among CD patients was as 
follows: ileopancolitis in 3 and ileocecal in 6. Two patients 
have upper GIT involvement. Five patients were given 
multiple empirical treatments for amebiasis prior to 
referral to our hospital. None of these patients was 
investigated before receiving the anti-amoebic treatment. 
 
Treatments 
In addition to supportive therapy patients were treated 
with systemic steroids, salazopyrine, 5-ASA derivatives and 
metronidazole in various combinations. Azathioprine was 
used for 3 patients. Budesonide enema was highly 
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effective in 3 patients with colitis. Nutritionally defined 
formula was available for use only on 2 occasions. 
 
Table 2 total and individual prevalence rates of different forms 
of juvenile onset IBD in the studied governorates*. 
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*Values between brackets represent prevalence rates per 100,000 
children  
Discussion 
We show that juvenile onset IBD is not so rare in the 
eastern part of Libya, with a prevalence rate of 3.6 per 
100,000 in 2006.  Though our clinic at AFCH looks after 
most children with suspected and/or diagnosed IBD, we 
can not assume that all IBD cases are referred to AFCH, 
particularly those with milder forms of the disease. 
However, even on keeping this limitation in mind the 
prevalence and incidence rates of IBD are obviously lower 
than the rates in Western countries, where rates of 2.2-
7/100,000 per year were reported [15-18]. A similar study 
from Saudi Arabia reported a prevalence of 5 per 100,000 
[10] which is quite similar to ours.  In addition, another 
study from Saudi Arabia pointed to a low rate of IBD, 
though no exact prevalence figures were reported. In their 
report, Isbister and Hubler described just 101 IBD cases 
from Saudi Arabia during almost two decades (1976-1994) 
[19]. A relative exception to this comes from a study on 
adult Kuwaiti patients, in which 91 patients with UC and 
14 with CD were diagnosed over 6 years in a hospital 
serving 55% of the population of Kuwait [20]. The authors 
in this study suggested that IBD is likely to be common in 
Kuwait.  
 
Eastern Libya is characterized by having a more 
ethnically homogeneous population than that encountered 
in most of the Gulf countries which may account, at least 
partially, for the observed differences in prevalence rates. 
However, rest of Libya is ethnically less homogeneous and 
our results might not be applicable to the rest of it. 
Though most Libyans are of Arab ancestry, some have 
African roots, particularly in the south of the country. 
Ethnic heterogeneity in the epidemiology and phenotype 
of IBD is well known. For example, ethnic differences have 
been observed in the multiracial Asian countries. In 
addition, NOD2/CARD15 variants have not been found in 
Asian CD patients, indicating a different genetic 
background from Western CD patients [11]. The effect of 
race extends to involve the phenotype of IBD. In a report 
on characteristics of IBD among African Americans, 
Hispanics and non-Hispanic whites in north America, 
A f r i c a n  A m e r i c a n  C D  p a t i e n t s  w e r e  m o r e  l i k e l y  t o  h a v e  
gastroduodenal, colorectal and perianal disease and less 
likely to have ileal involvement [21]. Some European 
countries reported a relatively low incidence of IBD in 
children [18]. From the above we could see that the rates 
of occurrence of IBD have no consistent pattern among 
western countries and it would be an oversimplification to 
generalize statements on the prevalence of IBD in 
developed and under-developed areas of the world. 
 
The prevalence of IBD has been increasing in western 
and non-western countries [10,22,23]. Since our clinic is 
for all practical purposes the only one looking after 
pediatric IBD cases in the eastern part of Libya, we have 
the unique position of knowing most children with IBD in 
our area. We had the impression that IBD locally is 
increasing. Our study showed that the incidence of IBD 
has increased fourfold in 2006 compared to 2002. We feel 
that this increase in the occurrence rate is most probably a 
real one since the diagnostic facilities have not changed 
much over these 5 years. This rise in occurrence might be 
a result of the westernization of the local life style. It has 
been observed that IBD incidence has increased in urban 
areas [24]. Urbanization of lifestyle embodies changes in 
diet and environment. For example, non-nutritive 
microparticles such as titanium dioxide are found in the 
diet. These microparticles are believed to combine with 
other substances found in the intestine to form antigens 
capable of mediating inflammatory immune responses. 
Patients with IBD were also shown to consume higher 
amounts of sucrose and refined carbohydrates [25]. Table 
sugar is subsidized by the Libyan government, resulting in 
high consumption rates. Such dietary changes might have 
contributed to the observed rise in IBD incidence in our 
area. On the other hand, IBD is more likely to occur in 
people exposed to dirt and helminthes [26,27].  However, 
we can not eliminate the possibility of increased 
awareness of the disease as a contributing factor to the 
rise in the incidence. 
 
Though AFCH is the only hospital at which young 
children from eastern Libya with suspected IBD are 
evaluated, we can not claim that every child with IBD is 
referred to us. It is possible that some patients did not 
find their way to us either because of less awareness of 
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the disease in governorates other than Benghazi or 
because they managed to get medical advice in nearby 
countries. For all these reasons, it is likely that the actual 
prevalence and incidence figures are higher than those we 
got. 
 
Table 3 comparison between percent frequencies of some of the 
clinical features of IBD in Great Britain and Ireland 29 and those 
seen in our patients 
  Ulcerative colitis  Crohn’s disease 
  UK 
(n=172) 
n (%) 
Libya 
(n=6) 
n (%) 
UK 
(n=)379 
n (%) 
Libya 
(n=9) 
n (%) 
Abdominal 
pain 
106 (62)  4 (66)  274 
(72) 
5 (56) 
Diarrhea 
127 (74)  3 (50)  214 
(56) 
7 (77) 
Rectal 
bleeding 
145 (84)  6 (100)  84 (22)  2 (22) 
Weight 
loss 
53 (31)  4 (66)  220 
(58) 
5 (56) 
Anorexia  11 (06)  3 (50)  94 (25)  5 (56) 
Perianal 
disease 
Not 
mentioned 
0  17 (6.6)  4 (44) 
 
Interestingly, the prevalence rates of CD and UC in 
Benghazi were equal (3 per 105). This is in contrast to 
reports from western countries which show that UC is 
significantly more common [18,22].  This opposite trend is 
increased further if we include patients from other 
governorates where CD outnumbers UC. It is known that 
dietary factors and intestinal microflora play an important 
role in IBD. The different dietary habits prevalent locally 
and the higher rate of early childhood infections might 
have something to do with this difference between 
ulcerative colitis and Crohn’s disease [28]. The 
p r e d o m i n a n c e  o f  U C  i s  n o t  u n i v e r s a l  i n  i n d u s t r i a l i z e d  
countries. A report from France shows predominance of 
CD over UC, a trend similar to ours. However, because of 
the small number of cases in our study we stress that such 
comparisons need to be taken with caution.  
 
The clinical features of Crohn’s disease and ulcerative 
colitis in the Libyan patients were similar to those reported 
from western and non-western countries. Common 
presenting features in our patients were diarrhea, 
abdominal pain, weight loss, anorexia and bleeding. A 
study carried out on presenting features of IBD in Great 
Britain and Ireland showed a very similar pattern to ours 
[29]. This was somewhat unexpected finding in view of 
our small sample size and in view of the epidemiological 
differences between these European countries and Libya. 
Table 3 compares our finding with theirs. 
 
Because IBD in Libya is considered by the local medical 
community as a rare disease, doctors tend to label 
patients with more common diagnoses. In this cohort, 5 
patients received blind treatment for amebiasis on a 
number of occasions. Such an empirical treatment might 
delay the diagnosis particularly if metronidazole is used. 
Though it is crucial to rule out more common diseases in 
developing countries, it is important not to miss IBD. 
Tuberculosis is seen in Libya more frequently nowadays 
than it was a decade ago and it has to be kept in mind as 
a differential diagnosis. Recently, a group of pediatric 
gastroenterologists released a report on the criteria for 
diagnosis of IBD. In this report, it was stressed that every 
child suspected of having IBD should be subjected to a 
complete diagnostic work up. This work up is composed of 
history, clinical examination, ileocolonoscopy, upper GIT 
endoscopy and in all cases a contrast small bowel study 
(with possible exception of obvious ulcerative colitis) [30]. 
Understandably, these recommendations are universal and 
need to be implemented locally as well. 
 
Conclusion 
In conclusion, we have shown that juvenile onset IBD is 
not that rare in Libya and its clinical features resemble 
those reported in other countries. It is also clear that 
childhood IBD is on the rise in Libya. Though it is 
important to exclude common infections, it is crucial to 
keep the possibility of IBD in mind. Studies on juvenile 
onset IBD in other parts of the country are highly needed 
as well. 
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